Literature DB >> 8566013

Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2Ab allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase.

M Brunner1, S Larsen, A Sette, A Mitchison.   

Abstract

The H-2Ab allele exerts a dominant down-regulatory effect on the anti-allo-HPPD (4-hydroxyphenylpyruvate dioxygenase) antibody response, through a hitherto unknown mechanism. In the present study, the allo-variable peptide bound to responder H-2Ak molecules with higher affinity than to H-2Ab ones, arguing against the operation of an affinity hierarchy. Quantitative polymerase chain reaction revealed differences in cytokine mRNA expression between suppressed and high-responder mice. Lymph node cells of responder but not suppressed mice contained high levels of interleukin (IL)-4 mRNA as early as 11 h post-immunization and continued to do so for at least 8 days; this early burst was paralleled by a small burst in transforming growth factor (TGF)-beta mRNA level. Differences in IL-12 mRNA were not detected, although an early IL-12 effect could not be excluded. Interferon (IFN)-gamma appeared to contribute to the suppression at later time points. Early treatment of responder mice with anti-IL-4 monoclonal antibody (11B11) down-regulated the antibody response. The proliferative T cell response from hyperimmunized mice was reduced but still detectable in the presence of an H-2Ab allele. Thus, in the presence of this allele, the Th1 response is enhanced and that of Th2 cells suppressed, apparently as a result of the bias of H-2Ab-restricted T cells in favor of the Th1 subset.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566013     DOI: 10.1002/eji.1830251213

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen dose.

Authors:  G Barcenas-Morales; M Merkenschlager; F Wahid; R Döffinger; J Ivanyi
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

Review 2.  Natural and induced regulation of Th1/Th2 balance.

Authors:  N A Mitchison; D Schuhbauer; B Müller
Journal:  Springer Semin Immunopathol       Date:  1999

3.  B cells in autoimmunity.

Authors:  N A Mitchison; L R Wedderburn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

Authors:  G Kingsley; J Sieper
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 5.  The importance of the back-signal from T cells into antigen-presenting cells in determining susceptibility to parasites.

Authors:  B Müller; A Mitchison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

6.  The in vivo antibody response against exogenous antigens is not influenced by the mouse Bcg (Nramp1) gene.

Authors:  M Sírová; O Hovorka; I Ríha; B Ríhová; M Baudys; S W Kim; E Skamene
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Regulation by non-major histocompatibility complex genes of the allo-4-hydroxy-phenylpyruvate dioxygenase (F liver protein) response.

Authors:  M C Brunner; N A Mitchison
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 8.  Modulating the Th1/Th2 balance in inflammatory arthritis.

Authors:  B Müller; U Gimsa; N A Mitchison; A Radbruch; J Sieper; Z Yin
Journal:  Springer Semin Immunopathol       Date:  1998

9.  Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects.

Authors:  M Baumgart; V Moos; D Schuhbauer; B Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo.

Authors:  Karin Knieke; Holger Hoff; Frank Maszyna; Paula Kolar; Arnhild Schrage; Alf Hamann; Gudrun F Debes; Monika C Brunner-Weinzierl
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.